What is Noopept?
Noopept is a synthetic, proline-containing dipeptide — a very small protein-like molecule made from two amino acid building blocks. Its full chemical name is N-phenylacetyl-L-prolylglycine ethyl ester. Scientists designed it by taking the structure of the classic nootropic drug piracetam and rebuilding it as a short peptide. The result was a compound that works at doses roughly 1,000 times lower than piracetam in preclinical models — making it one of the most potent synthetic nootropics studied to date.[4] It is classified as a research compound and is not approved as a medicine in most countries. Everything on this page refers to laboratory and preclinical research only.
How Noopept Works
Think of your brain's memory system like a filing cabinet. Piracetam, the older drug Noopept was modeled on, mainly helps you open the drawer — the early stage of storing a memory. Noopept appears to help with the whole process: opening the drawer, and organizing the files, and finding them again later. Preclinical research suggests it positively influences memory consolidation and retrieval, not just initial storage.[4]
On a cellular level, the picture gets more interesting. Research has shown that Noopept can activate a transcription factor called HIF-1 — basically a master switch inside cells that responds to low oxygen. Noopept appears to inhibit an enzyme that normally breaks HIF-1 down, letting it stay active longer and influence multiple gene pathways.[1] Separately, studies have found that Noopept can boost the expression of two important brain growth proteins: NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor) — molecules that help neurons survive and form new connections.[5] Importantly, researchers have also confirmed that Noopept does not stimulate uncontrolled cell growth or proliferation, which is a reassuring safety signal at the cellular level.[5]
Noopept also has antioxidant and anti-inflammatory properties, and in preclinical work it has been shown to reduce the toxicity of excess calcium and glutamate — two things that can damage neurons when they pile up.[4] One major practical advantage: unlike many peptides, Noopept retains its activity when taken orally, because the proline residue protects it from being broken down in the gut.[4]
What the Research Shows
Memory and Cognition
Early preclinical work established that Noopept outperforms piracetam across a broad range of memory tests in animal models, affecting not just early learning but also how memories are stored and later recalled.[4] It also showed a selective anxiolytic (anti-anxiety) effect alongside its memory benefits — an unusual combination.[4]
Brain Growth Factor Expression
In rat hippocampus tissue, chronic treatment with Noopept was associated with increased expression of NGF and BDNF — the brain's own repair and maintenance proteins.[5] These proteins are heavily researched in the context of neurodegenerative diseases and cognitive decline.
HIF-1 Activation
Cell-culture experiments showed Noopept increases both baseline and stress-induced activity of HIF-1, a transcription factor linked to cellular adaptation to low oxygen. The mechanism involves slowing the breakdown of HIF-1's oxygen-sensitive subunit.[1] This pathway is of broad interest in neuroscience and metabolic disease research.
Diabetes-Related Models
Several studies have explored Noopept in diabetic rat models. In prepubertal diabetic rats, Noopept administration was linked to lower blood glucose, reduced insulin resistance, normalization of delayed puberty, and fewer degenerated cells in the hippocampus and testes compared to untreated diabetic controls.[3] A separate histological study found Noopept was protective against diabetes-related damage to the cornea, retina, kidney, and pancreas.[2] In a prediabetes mouse model, Noopept significantly reduced DNA damage in pancreatic, liver, and kidney cells, an effect attributed to its antigenotoxic properties.[6]
Neuroprotection
Pronounced neuroprotective effects have been demonstrated in models of brain ischemia (reduced blood flow) both in live animals and in isolated cell cultures, with antioxidant and anti-excitotoxic mechanisms playing a central role.[4]
What Noopept Is Being Studied For
- Cognitive enhancement — improving memory consolidation and retrieval in preclinical models[4]
- Neuroprotection — defending neurons against ischemia, oxidative stress, and excitotoxicity[4]
- NGF and BDNF upregulation — boosting endogenous brain repair signals[5]
- Metabolic and diabetic complications — protecting organs and DNA in diabetic models[2][3][6]
- HIF-1 pathway modulation — exploring cellular oxygen-sensing mechanisms[1]
- Cognitive deficiency of cerebrovascular and post-traumatic origin — clinical tablet formulations have been under assessment[4]
How Noopept Is Dosed in Research
Doses vary widely depending on the research question, the animal model, and the route of administration. For a full breakdown — including preclinical doses used in rat cognition studies, diabetic models, and neuroprotection work — refer to the dosage chart on this page. If you need to scale or convert doses for research purposes, use the calculator provided on this site. Always design dosing protocols based on peer-reviewed literature and institutional guidelines.
Mixing and Storing Noopept
Noopept is typically supplied as a white lyophilized (freeze-dried) powder. For research use, it is commonly reconstituted by adding bacteriostatic water or sterile saline slowly to the vial — let the liquid run down the side rather than shooting it directly onto the powder, which can degrade the compound. Swirl gently; do not shake. Once reconstituted, store the solution at 2–8 °C (standard refrigerator temperature) and protect it from light. Lyophilized powder should be kept in a cool, dry place, ideally at −20 °C for long-term storage. Always label vials with the date of reconstitution and discard any solution that appears cloudy or discolored. As with all research peptides, handle using aseptic technique to avoid contamination.
Sources
- Cognitive Enhancer Noopept Activates Transcription Factor HIF-1. — Doklady. Biochemistry and biophysics, 2020. PMID 33119829.
- Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats. — Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2023. PMID 36946173.
- Effects of noopept on cognitive functions and pubertal process in rats with diabetes. — Life sciences, 2019. PMID 31356906.
- [The original novel nootropic and neuroprotective agent noopept]. — Eksperimental'naia i klinicheskaia farmakologiia, 2002. PMID 12596521.
- Drug with Neuroprotective Properties Noopept Does Not Stimulate Cell Proliferation. — Bulletin of experimental biology and medicine, 2019. PMID 30788746.
- Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes. — Bulletin of experimental biology and medicine, 2019. PMID 31776952.
EN
BR
ES
FR